- Home
- PDCO vs DYN Comparison
PDCO vs DYN Comparison
Compare PDCO & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDCO
- DYN
- Stock Information
- Founded
- PDCO 1877
- DYN 1984
- Country
- PDCO United States
- DYN United States
- Employees
- PDCO N/A
- DYN N/A
- Industry
- PDCO Medical Specialities
- DYN Medicinal Chemicals and Botanical Products
- Sector
- PDCO Health Care
- DYN Health Care
- Exchange
- PDCO Nasdaq
- DYN Nasdaq
- Market Cap
- PDCO 2.7B
- DYN 2.6B
- IPO Year
- PDCO 1992
- DYN 2020
- Fundamental
- Price
- PDCO $30.90
- DYN $14.13
- Analyst Decision
- PDCO Hold
- DYN Strong Buy
- Analyst Count
- PDCO 7
- DYN 10
- Target Price
- PDCO $27.10
- DYN $50.70
- AVG Volume (30 Days)
- PDCO 1.6M
- DYN 1.8M
- Earning Date
- PDCO 02-26-2025
- DYN 03-04-2025
- Dividend Yield
- PDCO 3.37%
- DYN N/A
- EPS Growth
- PDCO N/A
- DYN N/A
- EPS
- PDCO 1.72
- DYN N/A
- Revenue
- PDCO $6,554,872,000.00
- DYN N/A
- Revenue This Year
- PDCO $2.81
- DYN N/A
- Revenue Next Year
- PDCO $2.87
- DYN N/A
- P/E Ratio
- PDCO $17.92
- DYN N/A
- Revenue Growth
- PDCO 0.05
- DYN N/A
- 52 Week Low
- PDCO $19.45
- DYN $14.03
- 52 Week High
- PDCO $31.79
- DYN $47.45
- Technical
- Relative Strength Index (RSI)
- PDCO 80.85
- DYN 19.54
- Support Level
- PDCO $30.77
- DYN $14.79
- Resistance Level
- PDCO $30.99
- DYN $15.90
- Average True Range (ATR)
- PDCO 0.09
- DYN 1.55
- MACD
- PDCO -0.34
- DYN -0.82
- Stochastic Oscillator
- PDCO 66.67
- DYN 0.82
About PDCO Patterson Companies Inc.
Patterson Companies Inc is a dental distributor and wholesaler of consumable products and equipment operating through two business segments, Patterson Dental, and Patterson Animal Health. The company's segment includes Dental, Animal Health, and Corporate. It generates maximum revenue from the Animal Health segment. Geographically, it derives its revenue from the United States, the United Kingdom, and Canada. The firm derives almost all of its revenue from the United States.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.